Journal article
Prolonged COVID-19 symptom duration in people with systemic autoimmune rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance Vaccine Survey
Abstract
OBJECTIVE: We investigated prolonged COVID-19 symptom duration, defined as lasting 28 days or longer, among people with systemic autoimmune rheumatic diseases (SARDs).
METHODS: We analysed data from the COVID-19 Global Rheumatology Alliance Vaccine Survey (2 April 2021-15 October 2021) to identify people with SARDs reporting test-confirmed COVID-19. Participants reported COVID-19 severity and symptom duration, sociodemographics and clinical …
Authors
DiIorio M; Kennedy K; Liew JW; Putman MS; Sirotich E; Sattui SE; Foster G; Harrison C; Larché MJ; Levine M
Journal
RMD Open, Vol. 8, No. 2,
Publisher
BMJ
Publication Date
9 2022
DOI
10.1136/rmdopen-2022-002587
ISSN
2056-5933